TRAX
NASDAQFirst Tracks Biotherapeutics Inc.
SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations
News18/Ratings3
News · 26 weeks18+100%
2025-10-262026-04-19
Mix1890d
- Insider14(78%)
- Analyst3(17%)
- Other1(6%)
Latest news
18 items- INSIDERSEC Form 3 filed by new insider Tamboli Ajim3 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Tamboli Ajim4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- ANALYSTAnalyst initiated coverage on First Tracks Biotherapeutics with a new price targetAnalyst initiated coverage of First Tracks Biotherapeutics with a rating of Overweight and set a new price target of $31.00
- SECSEC Form SCHEDULE 13G filed by First Tracks Biotherapeutics Inc.SCHEDULE 13G - First Tracks Biotherapeutics, Inc. (0002091349) (Subject)
- INSIDERSEC Form 4 filed by Ecor1 Capital, Llc4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 3 filed by new insider Ecor1 Capital, Llc3 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 3 filed by new insider Stone Benjamin3 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 4 filed by Ware J. Anthony4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 4 filed by Lizzul Paul F.4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 4 filed by Jain Rita4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 4 filed by Orwin John A4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 4 filed by Schmid John P.4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 4 filed by Fenton Dennis M4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 4 filed by Marquet Magda4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 4 filed by Anaptysbio, Inc4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- INSIDERSEC Form 4 filed by Faga Daniel4 - First Tracks Biotherapeutics, Inc. (0002091349) (Issuer)
- ANALYSTBarclays initiated coverage on First Tracks Biotherapeutics with a new price targetBarclays initiated coverage of First Tracks Biotherapeutics with a rating of Overweight and set a new price target of $40.00
- ANALYSTUBS initiated coverage on First Tracks Biotherapeutics with a new price targetUBS initiated coverage of First Tracks Biotherapeutics with a rating of Buy and set a new price target of $45.00